Approximately 86.94% of the shareholders who voted at the shareholders meeting approved Ascendent's acquisition proposal; Approximately 76.95% of shareholders voted, underlining the competitive value that has been
Buyer Consortium will remain committed to acquiring Hollysys at US$29.50 per share after the proposed Ascendent transaction is rejected by shareholdersBuyer Consortium's offer provides more closing certainty than the
Shares of RayzeBio, Inc. (NASDAQ: RYZB) rose sharply during Tuesday’s session after the company announced that it will be acquired by Bristol Myers Squibb for $62.50 per share in cash in a deal worth $4.1 billion.
RayzeBio shares gained 100% to $61.38 on Tuesday.
Hollysys Automation Technologies Ltd (NASDAQ: HOLI) shares are trading higher today as the company got an increased acquisition offer from a buyer Consortium led by
Reiterates All-Cash Offer of US$26.50 Per Share while Noting Board is Negotiating a Deal without the Support of ShareholdersSpecial Meeting Must Happen Prior to Definitive Deal, Any Deal Announced Prior to Special
Buyer consortium ("the consortium") led by Recco Control Technology Pte. Ltd. ("Recco Control Technology") and Dazheng Group (Hong Kong) Investment Holdings Company Limited ("Dazheng Group") expressed its strong desire
Offer now represents a 42% premium to Hollysys' undisturbed closing share price on August 23, 2023 and a 28.6% premium to Hollysys' closing share price on November 3, 2023Further shareholder support for calling of
Gainers
Carbon Revolution Public Limited (NASDAQ: CREV) shares jumped 396.2% to $145.49 after gaining 100% on Friday. The company’s stock began trading on Friday following merger with Twin Ridge Capital Acquisition Corp.